Laxative Use in Chronic Kidney Disease

First-Line Options

Polyethylene glycol (PEG) is the safest and most effective first-line laxative for patients with CKD due to its minimal systemic absorption and good safety profile, according to the American College of Gastroenterology 1
Stimulant laxatives (senna, bisacodyl) are generally safe in renal impairment as they work locally in the intestine with minimal systemic absorption, as recommended by the American Gastroenterological Association 1, 2

Magnesium-containing laxatives (magnesium oxide, magnesium citrate) should be avoided in CKD due to risk of hypermagnesemia, as warned by the National Kidney Foundation 4, 5, 1
Sodium phosphate preparations should be avoided in renal impairment due to risk of electrolyte disturbances and potential for acute phosphate nephropathy, according to the American College of Nephrology 1, 6

Regular monitoring of renal function and electrolytes is essential when using laxatives in CKD patients, as advised by the American Society of Nephrology 1

Using magnesium-containing laxatives in CKD patients can lead to dangerous hypermagnesemia, as cautioned by the European Renal Association 5, 1
Using sodium phosphate enemas in CKD patients can cause severe electrolyte disturbances, as warned by the International Society of Nephrology 1, 6
Failing to adjust fluid intake appropriately when using osmotic laxatives in fluid-restricted CKD patients can lead to complications, as noted by the American Heart Association 7, 1

For distal fecal impaction identified on digital rectal exam, suppositories are preferred first-line therapy over enemas in CKD patients, as recommended by the American College of Gastroenterology 4, 7
Bisacodyl suppositories are preferred over sodium phosphate enemas in patients with renal impairment, according to the European Society of Gastroenterology 1, 6